Up to date Dec. 25, 2023 12:01 am ETOn a July day in 2018, Xiaolang Zhang headed to the San Jose, Calif., airport to board a flight to Beijing. He had handed
Novo Nordisk hiked its full-year steering Thursday as gross sales of its weight-loss drug Wegovy greater than doubled within the first 3 months of 2024. The Danish pharmaceutical massive, which become Europe’s
Viking Therapeutics Inc.’s inventory soared 100% early Tuesday, after the corporate introduced certain effects from a Section 2 trial of its weight-loss drug VK2735, a GLP-1 receptor agonist that it’s growing in